XML 81 R51.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies (Details 3) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues      
Total revenues $ 383,458 $ 559,386 $ 882,011
Parent [Member]      
Revenues      
Sale of medical equipment 212,394 342,344 882,011
Provision of OSAS diagnostic services 171,064 217,042
Total revenues 383,458 559,386 882,011
Cost of revenue      
Sale of medical equipment (112,942) (464,918) (1,655,970)
Provision of OSAS diagnostic services (630,802) (292,983)
Total cost of revenue (743,744) (757,901) (1,655,970)
Gross loss      
Sale of medical equipment 99,452 (122,574) (773,959)
Provision of OSAS diagnostic services (459,738) (75,941)
Total gross loss (360,286) (198,515) (773,959)
Depreciation and amortization expense:      
Sale of medical equipment 84,371 535,800 1,328,403
Provision of OSAS diagnostic services 693,746 291,830
Total depreciation and amortization expenses 778,117 827,630 1,328,403
Capital expenditure      
Sale of medical equipment 16,137 40,780
Provision of OSAS diagnostic services 760,191
Total capital expenditure $ 776,328 $ 40,780